IMLFF News and Press, InMed Pharmaceuticals Inc. From 08/02/19

InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes Canada NewsWire VANCOUVER, Aug. 2, 2019 TSX:IN OTCQX:IMLFF VANCOUVER , Aug. 2, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Compa...

Earlier this year I discussed why I am bearish overall on Cronos Group Inc ( CRON ), but I did note the company's partnership with Ginkgo Bioworks was a key part of the bull thesis. That partnership sees Ginkgo attempting produce cannabinoids via biosynthesis using yeast, rather than by ...

New York City-based OTC Markets Group (OTCQX: OTCM ) has launched a new index tracking marijuana stocks on its OTCQX Best Market. Called the OTCQX Cannabis Index, it officially made its debut on Tuesday (June 4) with an initial list of 30 marijuana stocks. “The exponential growth ...

Stacking Up Cannabis Stocks To The Bluechips This week, we compare many corporate fundamentals of the ‘Cannabis 50’ companies to the largest 50 of the S&P 500 companies. Investor euphoria over the past several years has been concentrated in the Monsters of Tech (Apple (AA...

NEW YORK , June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index (.OTCQXMJ), a new performance benchmark for cannabis companies tradin...

This week we focus on 50 cannabis companies for which we, as portfolio managers, capture comprehensive investor-related data. We show how we capture the data and apply it to a proprietary algorithm to generate decision-support information. We will let the data speak for itself. But new reade...

InMed Pharmaceuticals, Inc. (IMLFF) Q3 2019 Earnings Conference Call May 15, 2019, 13:00 ET Company Participants Josh Blacher - Chief Business Officer Eric Adams - President and CEO Jeff Charpentier - CFO Alexandra Mancini - SVP, Clinical and Regulatory Affairs Conference Ca...

InMed Pharmaceuticals ( OTCQX:IMLFF ): Q3 GAAP EPS of -C$0.02 misses by C$0.01 . Cash and cash equivalents of C$20.4M Press Release More news on: InMed Pharmaceuticals Inc., Earnings news and commentary, Tech stocks news, ,

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update Canada NewsWire VANCOUVER, May 15, 2019 VA...

TSX:IN OTCQX:IMLFF VANCOUVER, BC , May 8, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids...